{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T14:31:29Z","timestamp":1789396289204,"version":"build-2803163510"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T00:00:00Z","timestamp":1715558400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T00:00:00Z","timestamp":1715558400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Herzschr Elektrophys"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1007\/s00399-024-01016-y","type":"journal-article","created":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T17:01:52Z","timestamp":1715619712000},"page":"199-204","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Arrhythmien bei Amyloidose","Arrhythmias and amyloidosis"],"prefix":"10.1007","volume":"35","author":[{"given":"Maria","family":"Papathanasiou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara S.","family":"Schlender","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria Louise","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Wakili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,13]]},"reference":[{"key":"1016_CR1","doi-asserted-by":"publisher","first-page":"2872","DOI":"10.1016\/j.jacc.2019.04.003","volume":"73","author":"FL Ruberg","year":"2019","unstructured":"Ruberg\u00a0FL, Grogan\u00a0M, Hanna\u00a0M, Kelly\u00a0JW, Maurer\u00a0MS (2019) Transthyretin amyloid cardiomyopathy: JACC state-of-the-art review. J\u00a0Am Coll Cardiol 73:2872\u20132891","journal-title":"J Am Coll Cardiol"},{"key":"1016_CR2","doi-asserted-by":"publisher","first-page":"2585","DOI":"10.1093\/eurheartj\/ehv338","volume":"36","author":"E Gonz\u00e1lez-L\u00f3pez","year":"2015","unstructured":"Gonz\u00e1lez-L\u00f3pez\u00a0E, Gallego-Delgado\u00a0M, Guzzo-Merello\u00a0G et\u00a0al (2015) Wild-type transthyretin amyloidosis as a\u00a0cause of heart failure with preserved ejection fraction. Eur Heart\u00a0J 36:2585\u20132594","journal-title":"Eur Heart J"},{"key":"1016_CR3","doi-asserted-by":"publisher","DOI":"10.1161\/circimaging.116.005066","author":"TA Treibel","year":"2016","unstructured":"Treibel\u00a0TA, Fontana\u00a0M, Gilbertson\u00a0JA et\u00a0al (2016) Occult transthyretin cardiac amyloid in severe calcific aortic stenosis: prevalence and prognosis in patients undergoing surgical aortic valve replacement. Circ Cardiovasc Imaging. https:\/\/doi.org\/10.1161\/circimaging.116.005066","journal-title":"Circ Cardiovasc Imaging"},{"key":"1016_CR4","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1093\/europace\/euw161","volume":"18","author":"A Goette","year":"2016","unstructured":"Goette\u00a0A, Kalman\u00a0JM, Aguinaga\u00a0L et\u00a0al (2016) EHRA\/HRS\/APHRS\/SOLAECE expert consensus on atrial cardiomyopathies: definition, characterization, and clinical implication. Europace 18:1455\u20131490","journal-title":"Europace"},{"key":"1016_CR5","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1111\/bjh.12286","volume":"161","author":"JH Pinney","year":"2013","unstructured":"Pinney\u00a0JH, Smith\u00a0CJ, Taube\u00a0JB et\u00a0al (2013) Systemic amyloidosis in England: an epidemiological study. Br J Haematol 161:525\u2013532","journal-title":"Br J Haematol"},{"key":"1016_CR6","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1016\/j.jacep.2020.04.019","volume":"6","author":"E Donnellan","year":"2020","unstructured":"Donnellan\u00a0E, Wazni\u00a0OM, Hanna\u00a0M et\u00a0al (2020) Atrial fibrillation in transthyretin cardiac amyloidosis: predictors, prevalence, and efficacy of rhythm control strategies. JACC Clin Electrophysiol 6:1118\u20131127","journal-title":"JACC Clin Electrophysiol"},{"key":"1016_CR7","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1002\/ehf2.13851","volume":"9","author":"M Papathanasiou","year":"2022","unstructured":"Papathanasiou\u00a0M, Jakstaite\u00a0AM, Oubari\u00a0S et\u00a0al (2022) Clinical features and predictors of atrial fibrillation in patients with light-chain or transthyretin cardiac amyloidosis. ESC Heart Fail 9:1740\u20131748","journal-title":"ESC Heart Fail"},{"key":"1016_CR8","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.1161\/CIRCULATIONAHA.107.697763","volume":"116","author":"D Feng","year":"2007","unstructured":"Feng\u00a0D, Edwards\u00a0WD, Oh\u00a0JK et\u00a0al (2007) Intracardiac thrombosis and embolism in patients with cardiac amyloidosis. Circulation 116:2420\u20132426","journal-title":"Circulation"},{"key":"1016_CR9","doi-asserted-by":"publisher","first-page":"2490","DOI":"10.1161\/CIRCULATIONAHA.108.785014","volume":"119","author":"D Feng","year":"2009","unstructured":"Feng\u00a0D, Syed\u00a0IS, Martinez\u00a0M et\u00a0al (2009) Intracardiac thrombosis and anticoagulation therapy in cardiac amyloidosis. Circulation 119:2490\u20132497","journal-title":"Circulation"},{"key":"1016_CR10","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1016\/j.jacep.2019.10.013","volume":"5","author":"E Donnellan","year":"2019","unstructured":"Donnellan\u00a0E, Elshazly\u00a0MB, Vakamudi\u00a0S et\u00a0al (2019) No association between CHADS-VAsc score and left atrial appendage thrombus in patients with transthyretin amyloidosis. JACC Clin Electrophysiol 5:1473\u20131474","journal-title":"JACC Clin Electrophysiol"},{"key":"1016_CR11","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1002\/ejhf.2140","volume":"23","author":"P Garcia-Pavia","year":"2021","unstructured":"Garcia-Pavia\u00a0P, Rapezzi\u00a0C, Adler\u00a0Y et\u00a0al (2021) Diagnosis and treatment of cardiac amyloidosis. A\u00a0position statement of the European society of cardiology working group on myocardial and pericardial diseases. Eur J Heart Fail 23:512\u2013526","journal-title":"Eur J Heart Fail"},{"key":"1016_CR12","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1080\/13506129.2020.1810010","volume":"28","author":"LR Mitrani","year":"2021","unstructured":"Mitrani\u00a0LR, De Los Santos\u00a0J, Driggin\u00a0E et\u00a0al (2021) Anticoagulation with warfarin compared to novel oral anticoagulants for atrial fibrillation in adults with transthyretin cardiac amyloidosis: comparison of thromboembolic events and major bleeding. Amyloid 28:30\u201334","journal-title":"Amyloid"},{"key":"1016_CR13","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1161\/01.CIR.63.6.1285","volume":"63","author":"A Rubinow","year":"1981","unstructured":"Rubinow\u00a0A, Skinner\u00a0M, Cohen\u00a0AS (1981) Digoxin sensitivity in amyloid cardiomyopathy. Circulation 63:1285\u20131288","journal-title":"Circulation"},{"key":"1016_CR14","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.jacc.2018.10.079","volume":"73","author":"EA El-Am","year":"2019","unstructured":"El-Am\u00a0EA, Dispenzieri\u00a0A, Melduni\u00a0RM et\u00a0al (2019) Direct current cardioversion of atrial arrhythmias in adults with cardiac amyloidosis. J\u00a0Am Coll Cardiol 73:589\u2013597","journal-title":"J Am Coll Cardiol"},{"key":"1016_CR15","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.ahj.2020.01.002","volume":"222","author":"RS Loungani","year":"2020","unstructured":"Loungani\u00a0RS, Rehorn\u00a0MR, Geurink\u00a0KR et\u00a0al (2020) Outcomes following cardioversion for patients with cardiac amyloidosis and atrial fibrillation or atrial flutter. Am Heart\u00a0J 222:26\u201329","journal-title":"Am Heart J"},{"key":"1016_CR16","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1093\/europace\/euz314","volume":"22","author":"E Donnellan","year":"2020","unstructured":"Donnellan\u00a0E, Wazni\u00a0O, Kanj\u00a0M et\u00a0al (2020) Atrial fibrillation ablation in patients with transthyretin cardiac amyloidosis. Europace 22:259\u2013264","journal-title":"Europace"},{"key":"1016_CR17","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1111\/jce.13046","volume":"27","author":"NY Tan","year":"2016","unstructured":"Tan\u00a0NY, Mohsin\u00a0Y, Hodge\u00a0DO et\u00a0al (2016) Catheter ablation for atrial arrhythmias in patients with cardiac amyloidosis. J\u00a0Cardiovasc Electrophysiol 27:1167\u20131173","journal-title":"J Cardiovasc Electrophysiol"},{"key":"1016_CR18","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.amjcard.2020.05.021","volume":"128","author":"E Donnellan","year":"2020","unstructured":"Donnellan\u00a0E, Wazni\u00a0OM, Saliba\u00a0WI et\u00a0al (2020) Prevalence, incidence, and impact on mortality of conduction system disease in transthyretin cardiac amyloidosis. Am J Cardiol 128:140\u2013146","journal-title":"Am J Cardiol"},{"key":"1016_CR19","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1161\/CIRCULATIONAHA.108.843334","volume":"120","author":"C Rapezzi","year":"2009","unstructured":"Rapezzi\u00a0C, Merlini\u00a0G, Quarta\u00a0CC et\u00a0al (2009) Systemic cardiac amyloidoses: disease profiles and clinical courses of the 3 main types. Circulation 120:1203\u20131212","journal-title":"Circulation"},{"key":"1016_CR20","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1136\/heartjnl-2022-322315","volume":"110","author":"G Saturi","year":"2023","unstructured":"Saturi\u00a0G, De Frutos\u00a0F, Sguazzotti\u00a0M et\u00a0al (2023) Predictors and outcomes of pacemaker implantation in patients with cardiac amyloidosis. Heart 110:40\u201348","journal-title":"Heart"},{"key":"1016_CR21","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1016\/j.jacep.2020.04.020","volume":"6","author":"MR Rehorn","year":"2020","unstructured":"Rehorn\u00a0MR, Loungani\u00a0RS, Black-Maier\u00a0E et\u00a0al (2020) Cardiac implantable electronic devices: a\u00a0window into the evolution of conduction disease in cardiac amyloidosis. JACC Clin Electrophysiol 6:1144\u20131154","journal-title":"JACC Clin Electrophysiol"},{"key":"1016_CR22","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1093\/eurheartj\/ehu506","volume":"36","author":"RH Sayed","year":"2015","unstructured":"Sayed\u00a0RH, Rogers\u00a0D, Khan\u00a0F et\u00a0al (2015) A\u00a0study of implanted cardiac rhythm recorders in advanced cardiac AL amyloidosis. Eur Heart\u00a0J 36:1098\u20131105","journal-title":"Eur Heart J"},{"key":"1016_CR23","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1046\/j.1460-9592.2001.01228.x","volume":"24","author":"G Palladini","year":"2001","unstructured":"Palladini\u00a0G, Malamani\u00a0G, C\u00f2\u00a0C et\u00a0al (2001) Holter monitoring in AL amyloidosis: prognostic implications. Pacing Clinical Electrophis 24:1228\u20131233","journal-title":"Pacing Clinical Electrophis"},{"key":"1016_CR24","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1016\/j.amjcard.2009.05.040","volume":"104","author":"YB Goldsmith","year":"2009","unstructured":"Goldsmith\u00a0YB, Liu\u00a0J, Chou\u00a0J, Hoffman\u00a0J, Comenzo\u00a0RL, Steingart\u00a0RM (2009) Frequencies and types of arrhythmias in patients with systemic light-chain amyloidosis with cardiac involvement undergoing stem cell transplantation on telemetry monitoring. Am J Cardiol 104:990\u2013994","journal-title":"Am J Cardiol"},{"key":"1016_CR25","doi-asserted-by":"publisher","DOI":"10.1097\/01.tp.0000133517.20972.27","author":"R H\u00f6rnsten","year":"2004","unstructured":"H\u00f6rnsten\u00a0R, Wiklund\u00a0U, Olofsson\u00a0B\u2011O, Jensen\u00a0SM, Suhr\u00a0OB (2004) Liver transplantation does not prevent the development of life-threatening arrhythmia in familial amyloidotic polyneuropathy, Portuguese-type (ATTR val30met) patients. Transplantation. https:\/\/doi.org\/10.1097\/01.tp.0000133517.20972.27","journal-title":"Transplantation"},{"key":"1016_CR26","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.hrthm.2013.10.026","volume":"11","author":"BC Varr","year":"2014","unstructured":"Varr\u00a0BC, Zarafshar\u00a0S, Coakley\u00a0T et\u00a0al (2014) Implantable cardioverter-defibrillator placement in patients with cardiac amyloidosis. Heart Rhythm 11:158\u2013162","journal-title":"Heart Rhythm"},{"key":"1016_CR27","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12968-016-0240-7","volume":"18","author":"R Li","year":"2016","unstructured":"Li\u00a0R, Yang\u00a0ZG, Wen\u00a0LY et\u00a0al (2016) Regional myocardial microvascular dysfunction in cardiac amyloid light-chain amyloidosis: assessment with 3T cardiovascular magnetic resonance. J\u00a0Cardiovasc Magn Reson 18:16","journal-title":"J Cardiovasc Magn Reson"},{"key":"1016_CR28","doi-asserted-by":"publisher","first-page":"S125","DOI":"10.1016\/j.cardfail.2015.06.359","volume":"21","author":"S Alkindi","year":"2015","unstructured":"Alkindi\u00a0S, Almasoud\u00a0A, Younes\u00a0A et\u00a0al (2015) Increased risk of heart block in patients with cardiac amyloidosis on amiodarone. J\u00a0Cardiac Fail 21:S125","journal-title":"J Cardiac Fail"},{"key":"1016_CR29","doi-asserted-by":"publisher","first-page":"3997","DOI":"10.1093\/eurheartj\/ehac262","volume":"43","author":"K Zeppenfeld","year":"2022","unstructured":"Zeppenfeld\u00a0K, Tfelt-Hansen\u00a0J, de Riva\u00a0M et\u00a0al (2022) 2022 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: developed by the task force for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death of the European society of cardiology (ESC) endorsed by the association for European paediatric and congenital cardiology (AEPC). Eur Heart\u00a0J 43:3997\u20134126","journal-title":"Eur Heart J"},{"key":"1016_CR30","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1111\/pace.14458","volume":"45","author":"MT Brown","year":"2022","unstructured":"Brown\u00a0MT, Yalamanchili\u00a0S, Evans\u00a0ST et\u00a0al (2022) Ventricular arrhythmia burden and implantable cardioverter-defibrillator outcomes in transthyretin cardiac amyloidosis. Pacing Clin Electrophysiol 45:443\u2013451","journal-title":"Pacing Clin Electrophysiol"},{"key":"1016_CR31","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1111\/pace.14023","volume":"43","author":"E Donnellan","year":"2020","unstructured":"Donnellan\u00a0E, Wazni\u00a0OM, Hanna\u00a0M, Saliba\u00a0W, Jaber\u00a0W, Kanj\u00a0M (2020) Primary prevention implantable cardioverter-defibrillators in transthyretin cardiac amyloidosis. Pacing Clin Electrophysiol 43:1401\u20131403","journal-title":"Pacing Clin Electrophysiol"}],"container-title":["Herzschrittmachertherapie + Elektrophysiologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00399-024-01016-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00399-024-01016-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00399-024-01016-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T02:02:44Z","timestamp":1724810564000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00399-024-01016-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,13]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["1016"],"URL":"https:\/\/doi.org\/10.1007\/s00399-024-01016-y","relation":{},"ISSN":["0938-7412","1435-1544"],"issn-type":[{"value":"0938-7412","type":"print"},{"value":"1435-1544","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,13]]},"assertion":[{"value":"24 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"M.\u00a0Papathanasiou, L.S.\u00a0Schlender, V.L.\u00a0Johnson und R.\u00a0Wakili geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}